Tanshinone IIA potentiates the efficacy of 5-FU in Colo205 colon cancer cells in vivo through downregulation of P-gp and LC3-II

Experimental and Therapeutic Medicine

Volumn 3, Issue 3, 2012, Pages 555-559

  Su, Chin Cheng ^a,b,c  

^a CHANGHUA CHRISTIAN HOSPITAL   (Taiwan)

^b MINGDAO UNIVERSITY   (Taiwan)

^c CHINA MEDICAL UNIVERSITY   (Taiwan)

Author keywords

5 fluorouracil; Colo205; In vivo; Microtubule associated protein light chain 3 II; P glycoprotein; Tanshinone IIA

Indexed keywords

BETA ACTIN; CORN OIL; DNA TOPOISOMERASE; EPIDERMAL GROWTH FACTOR RECEPTOR 2; FLUOROURACIL; GELATINASE A; GLYCOPROTEIN P; MATRILYSIN; MICROTUBULE ASSOCIATED PROTEIN; PROTEIN BCL 2; PROTEIN LIGHT CHAIN 3 II; PROTEIN P21; PROTEIN P53; TANSHINONE IIA; UNCLASSIFIED DRUG; VASCULOTROPIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER CELL CULTURE; COLON CANCER; CONTROLLED STUDY; DOWN REGULATION; DRUG EFFICACY; DRUG POTENTIATION; HUMAN; HUMAN CELL; IN VIVO STUDY; MALE; MOUSE; NONHUMAN; PROTEIN EXPRESSION; TUMOR VOLUME; TUMOR XENOGRAFT; WESTERN BLOTTING;

EID: 84855856952     PISSN: 17920981     EISSN: 17921015     Source Type: Journal    
DOI: 10.3892/etm.2011.441     Document Type: Article

References (28)

1. Department of Health, Executive Yuan, Taipei, Taiwan R.O.C: Statistics of Causes of Death, 2007. p33, 2008.
2. Jemal A, Tiwari RC, Murray T, et al: Cancer statistics, 2004. CA Cancer J Clin 54: 8-29, 2004.
3. Wei SC, Su YN, Tsai-Wu JJ, et al: Genetic analysis of the APC gene in Taiwanese familial adenomatous polyposis. J Biomed Sci11: 260-265, 2004.
4. Verhoef MJ, Balneaves LG, Boon HS and Vroegindewey A: Reasons for and characteristics associated with complementary and alternative medicine use among adult cancer patients: a systematic review. Integr Cancer Ther 4: 274-286, 2005.
5. Boon H and Wong J: Botanical medicine and cancer: a review of the safety and efficacy. Expert Opin Pharmacother 5: 2485-2501, 2004.
6. Fish JM, Welchons DR, Kim YS, Lee SH, Ho WK and Antzelevitch C: Dimethyl lithospermate B, an extract of Danshen, suppresses arrhythmogenesis associated with the Brugada syndrome. Circulation 113: 1393-1400, 2006.
7. Chang PN, Mao JC, Huang SH, et al: Analysis of cardio-protective effects using purified Salvia miltiorrhiza extract on isolated rat hearts. J Pharmacol Sci 101: 245-249, 2006.
8. Che AJ, Zhang JY, Li CH, Chen XF, Hu ZD and ChenXG: Separation and determination of active components in Radix Salviae miltiorrhizae and its medicinal preparations by nonaqueous capillary electrophoresis. J Sep Sci 27: 569-575, 2004.
9. Zhou L, Zuo Z and Chow MS: Danshen: an overview of its chemistry, pharmacology, pharmacokinetics, and clinical use. JμClin Pharmacol 45: 1345-1359, 2005.
10. Jang SI, Kim HJ, Kim YJ, Jeong SI and You YO: Tanshinone IIA inhibits LPS induced NF-kappaB activation in RAW 264.7 cells: possible involvement of the NIK-IKK, ERK1/2, p38 and JNK pathways. Eur J Pharmacology 542: 1-7, 2006.
11. Li W, Li J, Ashok M, Wu R, et al: A cardiovascular drug rescues mice from lethal sepsis by selectively attenuating a late acting pro-inflammatory mediator, high mobility group box 1. JμImmunology 78: 3856-3864, 2007.
12. Lin R, Wang WR, Liu JT, Yang GD and Han CJ: Protective effect of Tanshinone IIA on human umbilical vein endo-thelial cell injured by hydrogen peroxide and its mechanism. JμEthnopharmacol 108: 217-222, 2006.
13. Wang AM, Sha SH, Lesniak W and Schacht J: Tanshinone (Salviae miltiorrhizae extract) preparations attenuate aminogly-coside-induced free radical formation in vitro and ototoxicity in vivo. Antimicrob Agents Chemother 47: 1836-1841, 2003.
14. Su CC, Chen GW, Kang JC and Chan MH: Growth inhibition and apoptosis induction by tanshinone IIA in human colon adenocarcinoma cells. Planta Med 74: 1357-1362, 2008.
15. Su CC and Lin YH: Tanshinone IIA inhibits human breast cancer cells through increased Bax to Bcl-xL ratios. Int J Mol Med 22: 357-361, 2008.
16. Chau I, Norman AR, Cunningham D, et al: A randomised comparison between 6 months of bolus fluorouracil/leucovorin and 12 weeks of protracted venous infusion fluorouracil as adjuvant treatment in colorectal cancer. Ann Oncol 16: 549-557, 2005.
17. Chen HC, Hsieh WT, Chang WC and Chung JG: Aloe-emodin induced in vitro G2/M arrest of cell cycle in human promyelocytic leukemia HL-60 cells. Food Chem Toxicol 42: 1251-1257, 2004.
18. Bradford MM: A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72: 248-254, 1976.
19. Gottesman MM, Pastan I and Ambudkar SV: P-glycoprotein and multidrug resistance. Curr Opin Genet Dev 6: 610-617, 1996.
20. Lum BL, Gosland MP, Kaubisch S and Sikic BI: Molecular targets in oncology: implications of the multidrug resistance gene. Pharmacotherapy 13: 88-109, 1993.
21. Li J, Hou N, Faried A, Tsutsumi S, Takeuchi T and KuwanoH: Inhibition of autophagy by 3-MA enhances the effect of 5-FU-induced apoptosis in colon cancer cells. Ann Surg Oncol16: 761-771, 2009.
22. Albertsson P, Lennernäs B and Norrby K: Low-dose continuous 5-fluorouracil infusion stimulates VEGF-A-mediated angio-genesis. Acta Oncol 48: 418-425, 2009.
23. Kirkegaard K, Taylor MP and Jackson WT: Cellular autophagy: Surrender, avoidance and subversion by microorganisms. Nat Rev Microbiol 2: 301-314, 2004.
24. Eskelinen EL, Prescott AR, Cooper J, et al: Inhibition of autophagy in mitotic animal cells. Traffic 3: 878-893, 2002.
25. Fang YJ, Lu ZH, Wang GQ, Pan ZZ, Zhou ZW, Yun JP, ZhangMF and Wan DS: Elevated expressions of MMP7, TROP2, and survivin are associated with survival, disease recurrence, and liver metastasis of colon cancer. Int J Colorectal Dis 24: 875-884, 2009.
26. Xu WL, Liu JR, Liu HK, Qi GY, Sun XR, Sun WG and Chen BQ: Inhibition of proliferation and induction of apoptosis by gamma-tocotrienol in human colon carcinoma HT-29 cells. Nutrition 25: 555-566, 2009.
27. He D, Xu Q, Yan M, Zhang P, Zhou X, Zhang Z, Duan W, ZhongL, Ye D and Chen W: The NF-kappa B inhibitor, celastrol, could enhance the anti-cancer effect of gambogic acid on oral squamous cell carcinoma. BMC Cancer 9: 343, 2009.
28. Voboril R, Hochw SN, Li J, Brank A, Weberova J, WesselsF, Moldawer LL, Camp ER and MacKay SL: Inhibition of NF-kappa B augments sensitivity to 5-fluorouracil/folinic acid in colon cancer. J Surg Res 120: 178-188, 2004.